Kintara Therapeutics (NASDAQ:KTRA) reported quarterly losses of $(0.23) per share. This is a 35.29 percent decrease over losses of $(0.17) per share from the same period last year.
Is Apple Letting Disney+ Silently Hike Subscription Fees?
Apple Inc (NASDAQ: AAPL) is testing a feature wherein users will only be intimated of subscription price hikes by applications and no further opt-ins would be necessary.